| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.57 | 0.001 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.57 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |